|
Originally published In Press as doi:10.1074/jbc.M209911200 on January 13, 2003
J. Biol. Chem., Vol. 278, Issue 12, 10232-10238, March 21, 2003
Nitric Oxide Donors Inhibit Luciferase Expression in a
Promoter-independent Fashion*
Xian
Fan ,
Eileen
Roy,
Liping
Zhu,
Tamara C.
Murphy,
Mirek
Kozlowski,
Mark S.
Nanes, and
Janet
Rubin
From the Department of Medicine, Emory University Medical School
and Veterans Affairs Medical Center, Atlanta, Georgia 30033
Nitric oxide (NO) is an important molecule
with diverse bio-messenger functions including regulation of gene
expression. Transcriptional studies using sensitive luciferase reporter
systems have suggested that NO inhibits the promoter activity of a
variety of genes. Here we report that NO donors (sodium
nitroprusside, 2',2'-(hydroxynitrosohydrazono)bis-ethanimine, and
(±)-(E)-4-ethyl-2-[(Z)-hydroxyimino]-5-nitro-3-hexen-1-yl-nicotinamide) decrease luciferase activity in a promoter-independent fashion in both
viral and eukaryotic promoters, with a reduction to nearly 50% in the
presence of 100 µM NO donor. Addition of an SV40 enhancer downstream of the luciferase coding region shifted NO donor inhibition to the right, with inhibition at ~300 µM. In contrast,
when studied in a chloramphenicol acetyltransferase reporter, two
promoters indicating inhibition by NO were unaffected. The decrease in
luciferase activity was not caused by NO suppression of the luciferase
enzyme. Real-time PCR data showed that luciferase mRNA half-life
decreased by nearly half in the presence of NO donor (from 75 to 45 min). The SV40 enhancer prolonged luciferase mRNA half-life and
somewhat blunted the NO effect. Our data suggest that exogenous NO
inhibits luciferase activity in a dose-dependent manner
through decreasing luciferase mRNA stability. Thus, the use of
luciferase reporter systems to study transcriptional regulation by NO
should be attempted with caution.
*
This work was supported by Department of Veterans Affairs
Merit and Research Enhancement Award Program grants and National Institutes of Health Grant AR42360.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: VAMC-151, Emory
University/VA Medical Center, 1670 Clairmont Rd., Decatur, GA 30033.
Tel.: 404-321-6111 x6141; Fax: 404-728-7780; E-mail:
xfan@emory.edu.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Backlund, K. Paukku, L. Daviet, R. A. De Boer, E. Valo, S. Hautaniemi, N. Kalkkinen, A. Ehsan, K. K. Kontula, and J. Y. A. Lehtonen
Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase
Nucleic Acids Res.,
April 1, 2009;
37(7):
2346 - 2358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Martinez-Moreno, A. Martinez-Ruiz, A. Alvarez-Barrientos, F. Gavilanes, S. Lamas, and I. Rodriguez-Crespo
Nitric Oxide Down-regulates Caveolin-3 Levels through the Interaction with Myogenin, Its Transcription Factor
J. Biol. Chem.,
August 10, 2007;
282(32):
23044 - 23054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rubin, T. C. Murphy, J. Rahnert, H. Song, M. S. Nanes, E. M. Greenfield, H. Jo, and X. Fan
Mechanical Inhibition of RANKL Expression Is Regulated by H-Ras-GTPase
J. Biol. Chem.,
January 20, 2006;
281(3):
1412 - 1418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W. Raines, G.-L. Cao, S. Porsuphatana, P. Tsai, G. M. Rosen, and P. Shapiro
Nitric Oxide Inhibition of ERK1/2 Activity in Cells Expressing Neuronal Nitric-oxide Synthase
J. Biol. Chem.,
February 6, 2004;
279(6):
3933 - 3940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Fan, E. Roy, L. Zhu, T. C. Murphy, C. Ackert-Bicknell, C. M. Hart, C. Rosen, M. S. Nanes, and J. Rubin
Nitric Oxide Regulates Receptor Activator of Nuclear Factor-{kappa}B Ligand and Osteoprotegerin Expression in Bone Marrow Stromal Cells
Endocrinology,
February 1, 2004;
145(2):
751 - 759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rubin, T. C. Murphy, L. Zhu, E. Roy, M. S. Nanes, and X. Fan
Mechanical Strain Differentially Regulates Endothelial Nitric-oxide Synthase and Receptor Activator of Nuclear {kappa}B Ligand Expression via ERK1/2 MAPK
J. Biol. Chem.,
September 5, 2003;
278(36):
34018 - 34025.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|